Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1981 Aug;68(2):413–421. doi: 10.1172/JCI110270

Biochemical and Functional Abnormalities in Lymphocytes from an Adenosine Deaminase-deficient Patient during Enzyme Replacement Therapy

John J Hutton 1,2,3,4, Dan A Wiginton 1,2,3,4, Mary S Coleman 1,2,3,4, Steven A Fuller 1,2,3,4, Susan Limouze 1,2,3,4, Beatrice C Lampkin 1,2,3,4
PMCID: PMC370813  PMID: 7263861

Abstract

Biochemical and immunological properties of lymphocytes were measured repetitively over a period of 40 mo during enzyme replacement by transfusion in a child with adenosine deaminase (ADA) deficiency and severe combined immunodeficiency disease. Catalytically defective ADA protein is present in the child's cells. ADA activity in his lymphocytes is 7 nmol/min per 108 cells with 51 ng of ADA protein/108 cells by radioimmunoassay. ADA activities in normal cord and adult lymphocytes average 193 and 92 nmol/min per 108 cells, respectively, with 429 and 223 ng of ADA protein/108 cells. Deoxy(d)ATP accumulates in the patient's erythrocytes and lymphocytes. Transfusion of irradiated packed erythrocytes partially corrects the metabolic defects. Frank metabolic relapse occurs if transfusions are discontinued for several months. The amounts of dATP in erythrocytes and lymphocytes averaged 13 and 2 times normal, respectively, during periods when transfusions were administered every 2-4 wk. Deoxyguanosine triphosphate and deoxycytidine triphosphate in lymphocytes were normal on 11 occasions, but deoxyribosylthymine triphosphate was ninefold increased. On 11 occasions dATP was measured in lymphocytes and erythrocytes isolated simultaneously. There was a positive, but statistically insignificant, correlation between amounts of dATP in the two types of cells (r = 0.25,P > 0.1). The absolute peripheral lymphocyte count was correlated with the activity of ADA in circulating erythrocytes and with the response of lymphocytes to phytohemagglutinin (r = 0.64, P < 0.01; r = 0.49, P < 0.05). Response of lymphocytes to stimulation by phytohemagglutinin in vitro and absolute peripheral lymphocyte counts were not significantly correlated with levels of dATP in the erythrocyte or lymphocyte during periods of intensive therapy. Although there was objective improvement during enzyme replacement, the child remained immunodeficient and biochemically abnormal.

Full text

PDF
413

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Carson D. A., Goldblum R., Seegmiller J. E. Quantitative immunoassay of adenosine deaminase in combined immunodeficiency disease. J Immunol. 1977 Jan;118(1):270–273. [PubMed] [Google Scholar]
  2. Carson D. A., Kaye J., Matsumoto S., Seegmiller J. E., Thompson L. Biochemical basis for the enhanced toxicity of deoxyribonucleosides toward malignant human T cell lines. Proc Natl Acad Sci U S A. 1979 May;76(5):2430–2433. doi: 10.1073/pnas.76.5.2430. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Carson D. A., Kaye J., Seegmiller J. E. Lymphospecific toxicity in adenosine deaminase deficiency and purine nucleoside phosphorylase deficiency: possible role of nucleoside kinase(s). Proc Natl Acad Sci U S A. 1977 Dec;74(12):5677–5681. doi: 10.1073/pnas.74.12.5677. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Cohen A., Hirschhorn R., Horowitz S. D., Rubinstein A., Polmar S. H., Hong R., Martin D. W., Jr Deoxyadenosine triphosphate as a potentially toxic metabolite in adenosine deaminase deficiency. Proc Natl Acad Sci U S A. 1978 Jan;75(1):472–476. doi: 10.1073/pnas.75.1.472. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Coleman M. S., Donofrio J., Hutton J. J., Hahn L., Daoud A., Lampkin B., Dyminski J. Identification and quantitation of adenine deoxynucleotides in erythrocytes of a patient with adenosine deaminase deficiency and severe combined immunodeficiency. J Biol Chem. 1978 Mar 10;253(5):1619–1626. [PubMed] [Google Scholar]
  6. Daddona P. E., Frohman M. A., Kelley W. N. Human adenosine deaminase and its binding protein in normal and adenosine deaminase-deficient fibroblast cell strains. J Biol Chem. 1980 Jun 25;255(12):5681–5687. [PubMed] [Google Scholar]
  7. Daddona P. E., Frohman M. A., Kelley W. N. Radioimmunochemical quantitation of human adenosine deaminase. J Clin Invest. 1979 Sep;64(3):798–803. doi: 10.1172/JCI109526. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Donofrio J., Coleman M. S., Hutton J. J., Daoud A., Lampkin B., Dyminski J. Overproduction of adenine deoxynucleosides and deoxynucletides in adenosine deaminase deficiency with severe combined immunodeficiency disease. J Clin Invest. 1978 Oct;62(4):884–887. doi: 10.1172/JCI109201. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Dyminski J. W., Daoud A., Lampkin B. C., Limouze S., Donofrio J., Coleman M. S., Hutton J. J. Immunological and biochemical profiles in response to transfusion therapy in an adenosine deaminase-deficient patient with severe combined immunodeficiency disease. Clin Immunol Immunopathol. 1979 Nov;14(3):307–326. doi: 10.1016/0090-1229(79)90157-0. [DOI] [PubMed] [Google Scholar]
  10. Edwards N. L., Gelfand E. W., Burk L., Dosch H. M., Fox I. H. Distribution of 5'-nucleotidase in human lymphoid tissues. Proc Natl Acad Sci U S A. 1979 Jul;76(7):3474–3476. doi: 10.1073/pnas.76.7.3474. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Giblett E. R., Anderson J. E., Cohen F., Pollara B., Meuwissen H. J. Adenosine-deaminase deficiency in two patients with severely impaired cellular immunity. Lancet. 1972 Nov 18;2(7786):1067–1069. doi: 10.1016/s0140-6736(72)92345-8. [DOI] [PubMed] [Google Scholar]
  12. Hershfield M. S., Kredich N. M., Ownby D. R., Ownby H., Buckley R. In vivo inactivation of erythrocyte S-adenosylhomocysteine hydrolase by 2'-deoxyadenosine in adenosine deaminase-deficient patients. J Clin Invest. 1979 Apr;63(4):807–811. doi: 10.1172/JCI109367. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Hirschhorn R., Paageorgiou P. S., Kesarwala H. H., Taft L. T. Amerioration of neurologic abnormalities after "enzyme replacement" in adenosine deaminase deficiency. N Engl J Med. 1980 Aug 14;303(7):377–380. doi: 10.1056/NEJM198008143030706. [DOI] [PubMed] [Google Scholar]
  14. Hirschhorn R., Ratech H. Isozymes of adenosine deaminase. Isozymes Curr Top Biol Med Res. 1980;4:131–157. [PubMed] [Google Scholar]
  15. Hirschhorn R., Roegner V., Jenkins T., Seaman C., Piomelli S., Borkowsky W. Erythrocyte adenosine deaminase deficiency without immunodeficiency. Evidence for an unstable mutant enzyme. J Clin Invest. 1979 Oct;64(4):1130–1139. doi: 10.1172/JCI109552. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Hirschhorn R., Roegner V., Rubinstein A., Papageorgiou P. Plasma deoxyadenosine, adenosine, and erythrocyte deoxyATP are elevated at birth in an adenosine deaminase-deficient child. J Clin Invest. 1980 Mar;65(3):768–771. doi: 10.1172/JCI109725. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Jerrells T. R., Dean J. H., Richardson G. L., Herberman R. B. Depletion of monocytes from human peripheral blood mononuclear leukocytes: comparison of the sephadex G-10 column method with other commonly used techniques. J Immunol Methods. 1980;32(1):11–29. doi: 10.1016/0022-1759(80)90113-1. [DOI] [PubMed] [Google Scholar]
  18. Kredich N. M., Martin D. V., Jr Role of S-adenosylhomocysteine in adenosinemediated toxicity in cultured mouse T lymphoma cells. Cell. 1977 Dec;12(4):931–938. doi: 10.1016/0092-8674(77)90157-x. [DOI] [PubMed] [Google Scholar]
  19. Meuwissen H. J., Pollara B. Combined immunodeficiency and inborn errors of purine metabolism. Blut. 1978 Oct 13;37(4):173–181. doi: 10.1007/BF00996718. [DOI] [PubMed] [Google Scholar]
  20. Mitchell B. S., Kelley W. N. Purinogenic immunodeficiency diseases: clinical features and molecular mechanisms. Ann Intern Med. 1980 Jun;92(6):826–831. doi: 10.7326/0003-4819-92-6-826. [DOI] [PubMed] [Google Scholar]
  21. North T. W., Bestwick R. K., Mathews C. K. Detection of activities that interfere with the enzymatic assay of deoxyribonucleoside 5'-triphosphates. J Biol Chem. 1980 Jul 25;255(14):6640–6645. [PubMed] [Google Scholar]
  22. Polmar S. H. Metabolic aspects of immunodeficiency disease. Semin Hematol. 1980 Jan;17(1):30–43. [PubMed] [Google Scholar]
  23. Polmar S. H., Stern R. C., Schwartz A. L., Wetzler E. M., Chase P. A., Hirschhorn R. Enzyme replacement therapy for adenosine deaminase deficiency and severe combined immunodeficiency. N Engl J Med. 1976 Dec 9;295(24):1337–1343. doi: 10.1056/NEJM197612092952402. [DOI] [PubMed] [Google Scholar]
  24. Rodbard D., Bridson W., Rayford P. L. Rapid calculation of radioimmunoassay results. J Lab Clin Med. 1969 Nov;74(5):770–781. [PubMed] [Google Scholar]
  25. Schmalstieg F. C., Mills G. C., Nelson J. A., May L. T., Goldman A. S., Goldblum R. M. Limited effect of erythrocyte and plasma infusions in adenosine deaminase deficiency. J Pediatr. 1978 Oct;93(4):597–603. doi: 10.1016/s0022-3476(78)80894-4. [DOI] [PubMed] [Google Scholar]
  26. Schmalstieg F. C., Nelson J. A., Mills G. C., Monahan T. M., Goldman A. S., Goldblum R. M. Increased purine nucleotides in adenosine deaminase-deficient lymphocytes. J Pediatr. 1977 Jul;91(1):48–51. doi: 10.1016/s0022-3476(77)80442-3. [DOI] [PubMed] [Google Scholar]
  27. Schrader W. P., Pollara B., Meuwissen H. J. Characterization of the residual adenosine deaminating activity in the spleen of a patient with combined immunodeficiency disease and adenosine deaminase deficiency. Proc Natl Acad Sci U S A. 1978 Jan;75(1):446–450. doi: 10.1073/pnas.75.1.446. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Siaw M. F., Mitchell B. S., Koller C. A., Coleman M. S., Hutton J. J. ATP depletion as a consequence of adenosine deaminase inhibition in man. Proc Natl Acad Sci U S A. 1980 Oct;77(10):6157–6161. doi: 10.1073/pnas.77.10.6157. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Wiginton D. A., Coleman M. S., Hutton J. J. Purification, characterization and radioimmunoassay of adenosine deaminase from human leukaemic granulocytes. Biochem J. 1981 May 1;195(2):389–397. doi: 10.1042/bj1950389. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Ziegler J. B., Lee C. H., Van der Weyden M. B., Bagnara A. S., Beveridge J. Severe combined immunodeficiency and adenosine deaminase deficiency: failure of enzyme replacement therapy. Arch Dis Child. 1980 Jun;55(6):452–457. doi: 10.1136/adc.55.6.452. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES